Implanet SA (IMPZY)
0.08
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
Implanet Total Assets (Quarterly): 11.76M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 11.76M |
June 30, 2023 | 15.85M |
June 30, 2023 | 15.85M |
December 31, 2022 | 15.52M |
June 30, 2022 | 16.74M |
June 30, 2022 | 16.74M |
December 31, 2021 | 18.91M |
June 30, 2021 | 20.30M |
June 30, 2021 | 20.30M |
December 31, 2020 | 10.70M |
June 30, 2020 | 9.339M |
June 30, 2020 | 9.339M |
December 31, 2019 | 10.81M |
June 30, 2019 | 11.49M |
June 30, 2019 | 11.49M |
December 31, 2018 | 10.12M |
Date | Value |
---|---|
June 30, 2018 | 12.65M |
June 30, 2018 | 12.65M |
December 31, 2017 | 15.07M |
June 30, 2017 | 16.60M |
June 30, 2017 | 16.60M |
December 31, 2016 | 17.40M |
June 30, 2016 | 16.13M |
June 30, 2016 | 16.13M |
December 31, 2015 | 17.81M |
June 30, 2015 | 23.30M |
June 30, 2015 | 23.30M |
December 31, 2014 | 17.70M |
June 30, 2014 | 26.07M |
June 30, 2014 | 26.07M |
December 31, 2013 | 33.04M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.339M
Minimum
Jun 2020
20.30M
Maximum
Jun 2021
14.34M
Average
15.52M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
DBV Technologies SA | 145.90M |
Cellectis SA | 334.27M |
PHAXIAM Therapeutics SA (DELISTED) | -- |
Genfit SA | 192.20M |
Innate Pharma SA | 203.61M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 11.95M |
Shareholders Equity (Quarterly) | -0.1923M |
Debt to Equity Ratio | -31.75 |
Current Ratio | 0.7148 |
Net Debt Paydown Yield | 0.79% |